Symptomatic Benign Prostate Hyperplasia: Impact on Partners' Quality of Life

By Mitropoulos D.   Anastasiou I.   Giannopoulou C.   Nikolopoulos P.   Alamanis C.   Zervas A.   Dimopoulos C.  

European Urology, Vol. 41, Iss. 3, 2002-03 ,pp. : 240-245

Elsevier

Access to resources Recommend Favorite

Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia

By Bruskewitz R.   Girman C.J.   Fowler J.   Rigby O.F.   Sullivan M.   Bracken R.B.   Fusilier H.A.   Kozlowski D.   Kantor S.D.   Johnson E.L.   Wang D.Z.   Waldstreicher J.   for the PLESS Study Group  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 670-678

Elsevier

Access to resources Recommend Favorite

Impact of Therapy Used in Clinical Practice on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Disease Progression

By Berges R.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 19-24

Elsevier

Access to resources Recommend Favorite

Nocturia and benign prostatic hyperplasia

By Yoshimura K.   Ohara H.   Ichioka K.   Terada N.   Matsui Y.   Terai A.   Arai Y.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 786-790

Elsevier

Access to resources Recommend Favorite

Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related Surgery

By Souverein P.C.   Erkens J.A.   de la Rosette J.J.M.C.H.   Leufkens H.G.M.   Herings R.M.C.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 528-534

Elsevier

Access to resources Recommend Favorite